13F-HR filed by Rosalind Advisors, Inc.
Rosalind Advisors, Inc. filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 37 holding rows worth $210,889,882.
- Accession
- 0001622627-25-000028
- Filer
- CIK 1622627
- Filed
- 2025-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 37 entries on the cover page, a total value of $210,889,882 stated on the cover page (in dollars after the unit check, H1), rows summing to $210,889,882 with VALUE read as dollars as filed, 13F file number 028-23857. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 3,300,389 | $33,003,890 | dollars as filed | |
| FENNEC PHARMACEUTICALS INC | 31447P100 | COMMON STOCK | 2,045,644 | $16,978,845 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 400,000 | $13,216,000 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 1,218,700 | $11,309,536 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 511,132 | $10,743,994 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 2,155,594 | $10,066,623 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 700,000 | $9,786,000 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 100,000 | $9,458,000 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 2,043,563 | $8,480,786 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 900,000 | $8,361,000 | dollars as filed | |
| MEDIWOUND LTD | M68830112 | COMMON STOCK | 407,061 | $7,884,771 | dollars as filed | |
| MYOMO INC | 62857J201 | COM NEW | 3,595,788 | $7,766,902 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 1,741,211 | $7,765,801 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 542,366 | $7,430,414 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 810,918 | $6,803,602 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 2,654,944 | $6,053,272 | dollars as filed | |
| INSPIREMD INC | 45779A846 | COM | 2,289,099 | $5,196,254 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 192,974 | $5,017,324 | dollars as filed | |
| PROFOUND MED CORP | 74319B502 | COM NEW | 692,185 | $4,083,891 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 223,627 | $3,935,835 | dollars as filed | |
| POLYPID LTD | M8001Q126 | COM | 975,462 | $3,443,380 | dollars as filed | |
| MIND MEDICINE MINDMED INC | 60255C885 | COM NEW | 420,000 | $2,725,800 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 157,725 | $1,783,081 | dollars as filed | |
| INMUNE BIO INC | 45782T955 | COM | 1,033,200 | $1,764,385 | dollars as filed | put |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 300,000 | $1,641,000 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 482,651 | $1,351,422 | dollars as filed | |
| TALPHERA INC | 00444T209 | COM NEW | 2,003,939 | $922,212 | dollars as filed | |
| BIOFRONTERA INC | 09077D209 | COM NEW | 976,448 | $694,742 | dollars as filed | |
| UROGEN PHARMA LTD | M96088905 | COM | 100,000 | $600,000 | dollars as filed | call |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 100,000 | $577,000 | dollars as filed | |
| SPDR SERIES TRUST | 78464A950 | PUT | 550,000 | $534,000 | dollars as filed | put |
| REPLIMUNE GROUP INC | 76029N906 | CALL | 231,800 | $515,650 | dollars as filed | call |
| SPDR S&P 500 ETF TR | 78462F953 | PUT | 250,000 | $432,500 | dollars as filed | put |
| ATYR PHARMA INC | 002120952 | COM NEW | 223,000 | $271,050 | dollars as filed | put |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 500,000 | $164,950 | dollars as filed | |
| IDEAYA BIOSCIENCES INC | 45166A902 | COM | 20,000 | $68,000 | dollars as filed | call |
| CRINETICS PHARMACEUTICALS IN | 22663K907 | COM | 52,700 | $57,970 | dollars as filed | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001622627-25-000028 | this filing | 2025-08-14 | acceptance time not in the bulk data set |